Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
apixaban (eliquis) (2 trials)
dabigatran (pradaxa) (1 trial)
phenprocoumon (liquamar) (2 trials)
acetylsalicylic acid (aspirin) (1 trial)
edoxaban (savaysa) (1 trial)
olmesartan (benicar) (1 trial)
flecainide (tambocor) (1 trial)
Atrial Fibrillation (Phase 4)
Atrial Flutter (Phase 4)
Heart Diseases (Phase 3)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 3)
Thrombosis (Phase 4)
Trials (6 total)
Trial APIs (7 total)